Findings published in Science Immunology resolve how human LAG-3 binds to its main ligand providing a better foundation for ...

contribute to the control of lymphocyte activation and death. The initial upregulation of FLIP levels after T-cell activation correlates with the early resistance of activated T cells to Fas ...

Immutep (IMMP) announces new findings published in Science Immunology that resolve how human lymphocyte activation gene 3 binds to its main ...

Clinical-stage company Immutep (ASX:IMM) has announced new findings published in Science Immunology that resolve how human ...

For more information on the trial, please visit clinicaltrials.gov (NCT06637865).

A study published in Nature Communications examined the use of calcium carbonate nanoparticles (CNPs) to improve the ...

MDX-2001 (Modex Therapeutics Inc.) was engineered as a potentially first-in-class tetraspecific lymphocyte activator and survival enhancement receptor (LASER) recognizing CD3 and CD28 on human T cells ...

Gradual lymphocyte activation with IL-12 partial agonist STK-026 maintains anti-tumor efficacy but escapes acute NK-mediated cytokine release and toxicities associated with WT IL-12 Session Name ...